1-[4-[(4-aminocyclohexyl)amino]-5-(1-piperidin-4-ylpyrazol-4-yl)pyrimidin-2-yl]indole-5-carbonitrile
C27H31N9 — CID 178082118
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[4-[(4-aminocyclohexyl)amino]-5-(1-piperidin-4-ylpyrazol-4-yl)pyrimidin-2-yl]indole-5-carbonitrile
1-[4-[(4-aminocyclohexyl)amino]-5-(1-piperidin-4-ylpyrazol-4-yl)pyrimidin-2-yl]indole-5-carbonitrile (PubChem CID 178082118) has the molecular formula C27H31N9 and a molecular weight of 481.61 g/mol. Its IUPAC name is 1-[4-[(4-aminocyclohexyl)amino]-5-(1-piperidin-4-ylpyrazol-4-yl)pyrimidin-2-yl]indole-5-carbonitrile.
Molecular Properties
| Compound Name | 1-[4-[(4-aminocyclohexyl)amino]-5-(1-piperidin-4-ylpyrazol-4-yl)pyrimidin-2-yl]indole-5-carbonitrile |
|---|---|
| PubChem CID | 178082118 |
| Molecular Formula | C27H31N9 |
| Molecular Weight | 481.61 g/mol |
| Exact Mass | 481.27 |
| IUPAC Name | 1-[4-[(4-aminocyclohexyl)amino]-5-(1-piperidin-4-ylpyrazol-4-yl)pyrimidin-2-yl]indole-5-carbonitrile |
| SMILES | N#Cc1ccc2c(ccn2-c2ncc(-c3cnn(C4CCNCC4)c3)c(NC3CCC(N)CC3)n2)c1 |
| InChI | InChI=1S/C27H31N9/c28-14-18-1-6-25-19(13-18)9-12-35(25)27-31-16-24(26(34-27)33-22-4-2-21(29)3-5-22)20-15-32-36(17-20)23-7-10-30-11-8-23/h1,6,9,12-13,15-17,21-23,30H,2-5,7-8,10-11,29H2,(H,31,33,34) |
| InChIKey | QIKLBVMOGUMKPI-UHFFFAOYSA-N |
| XLogP | 3.76 |
| TPSA | 122.40 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 481.61 |
| LogP ≤ 5 | 3.76 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 178082118 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.